Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 10—October 2014

Rapidly Growing Mycobacteria Associated with Laparoscopic Gastric Banding, Australia, 2005–2011

Hugh L. WrightComments to Author , Rachel Thomson, Alistair B. Reid, Robyn Carter, Paul B. Bartley, Peter Newton, and Christopher Coulter
Author affiliations: Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia (H.L. Wright); Gallipoli Medical Research Centre, Brisbane (R.M. Thomson); Wollongong Hospital, Woolongong, New South Wales, Australia (A.B. Reid, P. Newton); Pathology Queensland, Brisbane (R. Carter, C. Coulter); QML Pathology, Brisbane (P.B. Bartley); The Prince Charles Hospital, Brisbane (C. Coulter)

Main Article

Table 2

Susceptibilities of Mycobacterium spp. isolated in laparoscopic gastric banding to selected antimicrobial agents, Australia, 2005–2011

Antimicrobial agent M. fortuitum, no. (%), n = 11 M. abscessus, no. (%), n = 7
Amikacin 10 (91) 7 (100)
Cefoxitin 7 (64) 5 (71)
Clarithromycin 3 (27) 7 (100)
Ciprofloxacin 10 (91) 0
Minocycline 2 (18) 0
Imipenem 8 (80) 0
Trimethoprim/sulfamethoxozole 9 (82) 0
Amoxycillin/clavulanate 1 (13) 0

Main Article

Page created: September 12, 2014
Page updated: September 12, 2014
Page reviewed: September 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.